S.R.I.W.
Overview
S.R.I.W. is a Belgian investment company established in 1979, dedicated to fostering the economic development of the Walloon region by providing financial support to companies and projects that contribute to its growth. The company offers equity investments, subordinated loans, and convertible loans, primarily targeting unlisted companies across various sectors, including technology, healthcare, real estate, financial services, energy, biotechnology, life sciences, aerospace, digital, environment, agro-food, chemistry, and more. S.R.I.W. typically invests between €1 million and €25 million per portfolio company, taking both majority and minority stakes, and often seeks board representation. The company's investment strategy focuses on sectors such as real estate, metal engineering, and environmental technologies. S.R.I.W. is particularly interested in companies that are active in Wallonia and contribute to the region's economic development. The firm does not invest in steelmaking or the catering industry. S.R.I.W. often co-invests with other venture capitalists and tailors its capital solutions to each project, emphasizing tangible economic benefits for the local ecosystem. S.R.I.W. has a track record of supporting a diverse range of companies, including iSTAR Medical, Elium, Minoryx Therapeutics, VIRIDAXIS, ChromaCure, Imcyse, ITeos Therapeutics, haulogy, Ecophos, Inveneo, and Air Belgium. The firm has exited investments in companies such as Celyad, Minoryx Therapeutics, Mithra Pharmaceuticals, Lampiris, Pharmasimple, Ogeda, and Keybate. S.R.I.W.'s investment philosophy centers on contributing to the growth and transformation of Walloon businesses, aiming to make them more numerous, competitive, innovative, and sustainable, thereby positioning them effectively in international markets.
Investment Focus
- Companies based in Wallonia
- Active in sectors such as technology, healthcare, real estate, financial services, energy, biotechnology, life sciences, aerospace, digital, environment, agro-food, chemistry
- Unlisted companies
- Potential for economic development and job creation in the Walloon region
Portfolio Companies
Reach S.R.I.W. directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about S.R.I.W.
What sectors does S.R.I.W. invest in?
S.R.I.W. invests in Financial Services, Technology, Healthcare, Energy, Real Estate and Aerospace, and is based in Belgium. S.R.I.W. is listed as a institutional investor in the ConnectSafely investor database.
What stage does S.R.I.W. invest at?
S.R.I.W. backs companies at Seed, Early Stage, Growth, Late Stage and Buyout, writing cheques of 1M - 25M.
Which regions does S.R.I.W. invest in?
S.R.I.W. invests across Belgium.
What companies has S.R.I.W. invested in?
S.R.I.W.'s portfolio includes iTeos Therapeutics, Haulogy, Minoryx Therapeutics, iSTAR Medical, Elium, VIRIDAXIS, ChromaCure and Imcyse.
Last updated · Source: ConnectSafely investor database
